当前位置:首页 - 行情中心 - 雪榕生物(300511) - 财务分析 - 现金流量表

雪榕生物

(300511)

  

流通市值:35.92亿  总市值:41.54亿
流通股本:5.17亿   总股本:5.98亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金427,818,796.872,175,962,720.561,634,316,700.651,079,688,842.75
  收到的税费返还1,577.6---
  收到其他与经营活动有关的现金9,645,373.3334,262,531.6645,287,487.5633,600,357.16
  经营活动现金流入小计437,465,747.82,210,225,252.221,679,604,188.211,113,289,199.91
  购买商品、接受劳务支付的现金197,895,917.031,180,656,240.6953,529,925.75697,752,310.8
  支付给职工以及为职工支付的现金133,672,809.99496,760,241.16410,592,920.32286,499,629.86
  支付的各项税费4,503,655.226,757,758.5117,656,478.8312,884,048.89
  支付其他与经营活动有关的现金15,309,841.8968,849,364.8263,336,902.147,288,967.33
  经营活动现金流出小计351,382,224.111,773,023,605.091,445,116,2271,044,424,956.88
  经营活动产生的现金流量净额86,083,523.69437,201,647.13234,487,961.2168,864,243.03
二、投资活动产生的现金流量:
  收回投资收到的现金4,600,000-5,353,184.615,266,869.59
  处置固定资产、无形资产和其他长期资产收回的现金净额1,736,242.2318,131,019.5710,212,299.7310,096,020.53
  投资活动现金流入小计6,336,242.2318,131,019.5715,565,484.3415,362,890.12
  购建固定资产、无形资产和其他长期资产支付的现金21,139,903.61327,456,793.54302,856,810.92267,046,462.5
  支付其他与投资活动有关的现金--14,000-
  投资活动现金流出小计21,139,903.61327,456,793.54302,870,810.92267,046,462.5
  投资活动产生的现金流量净额-14,803,661.38-309,325,773.97-287,305,326.58-251,683,572.38
三、筹资活动产生的现金流量:
  吸收投资收到的现金-8,113,754.85226,784.19134,697.98
  其中:子公司吸收少数股东投资收到的现金-8,113,754.85--
  取得借款收到的现金69,590,0001,165,446,895.641,034,883,395.64949,883,395.64
  收到其他与筹资活动有关的现金78,000,00071,645,194.7953,434,606.4253,520,921.44
  筹资活动现金流入小计147,590,0001,245,205,845.281,088,544,786.251,003,539,015.06
  偿还债务支付的现金288,776,399.671,240,198,909.2937,629,937.61542,924,604.18
  分配股利、利润或偿付利息支付的现金10,973,913.2667,006,895.1653,899,574.7840,394,474.46
  支付其他与筹资活动有关的现金24,655,875.4274,422,348.2839,404,618.3414,406,675.3
  筹资活动现金流出小计324,406,188.351,381,628,152.641,030,934,130.73597,725,753.94
  筹资活动产生的现金流量净额-176,816,188.35-136,422,307.3657,610,655.52405,813,261.12
四、汇率变动对现金及现金等价物的影响-12,193.2526,728.93,568,457.94-222,211.65
五、现金及现金等价物净增加额-105,548,519.24-8,019,705.38,361,748.09222,771,720.12
  加:期初现金及现金等价物余额149,941,516.62157,961,221.92157,961,221.92157,961,221.92
  期末现金及现金等价物余额44,392,997.38149,941,516.62166,322,970.01380,732,942.04
补充资料:
  净利润--616,406,262.2--137,106,437.86
  资产减值准备-426,191,974.36--408,725.3
  固定资产和投资性房地产折旧-361,858,138.86-181,026,657.03
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-361,858,138.86-181,026,657.03
  无形资产摊销-8,299,590.72-3,870,483.26
  长期待摊费用摊销-5,133,059.9-2,488,357.56
  处置固定资产、无形资产和其他长期资产的损失--7,850,323.36-8,187,783.49
  固定资产报废损失-2,460,785.09-732,908.63
  公允价值变动损失-645,524.3--
  财务费用-97,156,153.41-60,708,606.59
  存货的减少-73,989,070.84--520,524.13
  经营性应收项目的减少-11,801,926.38-6,477,792.74
  经营性应付项目的增加-70,162,040.53--82,699,429.84
  其他---24,238,365.09
  现金的期末余额-149,941,516.62-380,732,942.04
  减:现金的期初余额-157,961,221.92-157,961,221.92
  现金及现金等价物的净增加额--8,019,705.3-222,771,720.12
公告日期2025-04-282025-04-282024-10-252024-08-29
审计意见(境内)标准无保留意见
TOP↑